BMB Reports : eISSN 1976-670X

Cited by CrossRef (10)

  1. Ran Sun, Na Hai, Biao Yang, JunChun Chen, Jing Li, Qiufei Li, Jinmin Zhao, Jiake Xu, Qian Liu, Bo Zhou. Pteryxin suppresses osteoclastogenesis and prevents bone loss via inhibiting the MAPK/Ca2+ signaling pathways mediated by ROS. Biomedicine & Pharmacotherapy 2023;165:114898
    https://doi.org/10.1016/j.biopha.2023.114898
  2. Mohammad Norouzi, Pierre Hardy. Clinical applications of nanomedicines in lung cancer treatment. Acta Biomaterialia 2021;121:134
    https://doi.org/10.1016/j.actbio.2020.12.009
  3. Marie Pereira, Enrico Petretto, Siamon Gordon, J. H. Duncan Bassett, Graham R. Williams, Jacques Behmoaras. Common signalling pathways in macrophage and osteoclast multinucleation. 2018;131
    https://doi.org/10.1242/jcs.216267
  4. Inyoung Kim, Jung Ha Kim, Kabsun Kim, Semun Seong, Nacksung Kim. The IRF2BP2-KLF2 axis regulates osteoclast and osteoblast differentiation. BMB Rep. 2019;52:469
    https://doi.org/10.5483/BMBRep.2019.52.7.104
  5. Inyoung Kim, Jung Ha Kim, Kabsun Kim, Semun Seong, Keun-Bae Lee, Nacksung Kim. IRF2 enhances RANKL-induced osteoclast differentiation via regulating NF-κB/NFATc1 signaling. BMB Rep 2021;54:482
    https://doi.org/10.5483/BMBRep.2021.54.9.070
  6. Su Hyun Jin, Hyunsoo Kim, Dong Ryun Gu, Keun Ha Park, Young Rae Lee, Yongwon Choi, Seoung Hoon Lee. Actin-binding LIM protein 1 regulates receptor activator of NF-κB ligand-mediated osteoclast differentiation and motility. BMB Rep. 2018;51:356
    https://doi.org/10.5483/BMBRep.2018.51.7.106
  7. Austin Arrigo, Angelina T. Regua, Mariana K. Najjar, Hui-Wen Lo. Tumor Suppressor Candidate 2 (TUSC2): Discovery, Functions, and Cancer Therapy. Cancers 2023;15:2455
    https://doi.org/10.3390/cancers15092455
  8. Jiae Lee, Han Saem Son, Hye In Lee, Gong-Rak Lee, You-Jin Jo, Seong-Eun Hong, Narae Kim, Minjeong Kwon, Nam Young Kim, Hyun Jin Kim, Yoo Jin Lee, Eun Kyoung Seo, Woojin Jeong. Skullcapflavone II inhibits osteoclastogenesis by regulating reactive oxygen species and attenuates the survival and resorption function of osteoclasts by modulating integrin signaling. FASEB j. 2019;33:2026
    https://doi.org/10.1096/fj.201800866RR
  9. Roman Uzhachenko, Akiko Shimamoto, Sanika S. Chirwa, Sergey V. Ivanov, Alla V. Ivanova, Anil Shanker. Mitochondrial Fus1/Tusc2 and cellular Ca2+ homeostasis: tumor suppressor, anti-inflammatory and anti-aging implications. Cancer Gene Ther 2022;29:1307
    https://doi.org/10.1038/s41417-022-00434-9
  10. Yanan Zhang, Haibin Nong, Yiguang Bai, Quan Zhou, Qiong Zhang, Mingfu Liu, Pan Liu, Gaofeng Zeng, Shaohui Zong. Conditional knockout of PDK1 in osteoclasts suppressed osteoclastogenesis and ameliorated prostate cancer-induced osteolysis in murine model. Eur J Med Res 2023;28
    https://doi.org/10.1186/s40001-023-01425-8